Lumida
/TRDA
⌘K
Entrada Therapeutics Inc

Entrada Therapeutics Inc

TRDA
$6.89USD+0.29%+0.02 today

MARKET CAP

267.5M

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $7

52W RANGE

$5
$16

AI Summary

Stalk
StalkMedium

Price has formed a bullish pivot point above the 9EMA and 20EMA through the flattening 50 SMA, signaling structural repair and medium-term mean reversion opportunity within an overall downtrend. However, short-term extension and RSI near overbought levels suggest waiting for a clean pullback into the rising EMAs near the recent support zone before committing. Patience for a retracement into the $7.00–$7.20 area aligns with the COMP strategy’s emphasis on confirmation and controlled engagement.

  • Strong Buy consensus with $20 median price target, implying 163% upside from $7.72 current price.
  • DSMB approved progression to Cohort 2 in ELEVATE-45-201 trial, confirming EEV tech safety and efficacy.
  • Earnings yield at -3.29% and weak profitability factors indicate persistent financial strain.
Full analysis →
Insider Trades62 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
May 4, 2026SellTRDANathan J DowdenPresident & COO30,000$8.54$267.5M-58.12%+39.76%$256.1K+0.00%10b5-1Stalk
May 4, 2026SellTRDANatarajan SethuramanPresident, Research & Develop.25,907$15.39$267.5M-58.12%+39.76%$398.8K-10.70%10b5-1Stalk
Apr 1, 2026SellTRDAKory James WentworthChief Financial Officer2,500$12.95$267.5M-58.12%+39.76%$32.4K-2.06%10b5-1Stalk
Mar 9, 2026SellTRDANathan J DowdenPresident & COO15,010$13.04$267.5M-58.12%+39.76%$195.8K-3.54%10b5-1Stalk
Mar 9, 2026SellTRDAKory James WentworthChief Financial Officer16,477$13.01$267.5M-58.12%+39.76%$214.4K-6.08%10b5-1Stalk
Mar 4, 2026SellTRDAKory James WentworthChief Financial Officer7,988$12.25$267.5M-58.12%+39.76%$97.9K-5.47%10b5-1Stalk
Mar 2, 2026SellTRDAKory James WentworthChief Financial Officer8,651$11.72$267.5M-58.12%+39.76%$101.4K-2.32%Stalk
Mar 2, 2026SellTRDANatarajan SethuramanPresident, Research & Develop.11,475$11.72$267.5M-58.12%+39.76%$134.5K-1.96%Stalk
Mar 2, 2026SellTRDANathan J DowdenPresident & COO21,261$11.72$267.5M-58.12%+39.76%$249.2K-3.90%Stalk
Mar 2, 2026SellTRDADipal DoshiCEO29,050$11.72$267.5M-58.12%+39.76%$340.6K-2.22%Stalk
Nov 21, 2025SellTRDAKory James WentworthChief Financial Officer8,910$9.98$267.5M-58.12%+39.76%$88.9K-7.49%10b5-1Stalk
Sep 2, 2025SellTRDAKory James WentworthChief Financial Officer1,734$5.43$267.5M-58.12%+39.76%$9.4K-1.44%Stalk
Sep 2, 2025SellTRDANathan J DowdenPresident & COO1,746$5.43$267.5M-58.12%+39.76%$9.5K-0.97%Stalk
Sep 2, 2025SellTRDANatarajan SethuramanPresident, Research & Develop.1,760$5.43$267.5M-58.12%+39.76%$9.6K-0.88%Stalk
Sep 2, 2025SellTRDADipal DoshiCEO8,723$5.43$267.5M-58.12%+39.76%$47.4K-2.06%Stalk
Apr 3, 2025BuyTRDAKory James WentworthChief Financial Officer11,134$2.10$267.5M-58.12%+39.76%$23.4K+8.59%Stalk
Mar 17, 2025SellTRDAKory James WentworthChief Financial Officer1,784$10.67$267.5M-58.12%+39.76%$19.0K-1.60%10b5-1Stalk
Mar 3, 2025SellTRDAKory James WentworthChief Financial Officer4,929$11.68$267.5M-58.12%+39.76%$57.6K-2.75%Stalk
Mar 3, 2025SellTRDANathan J DowdenPresident & COO5,144$11.68$267.5M-58.12%+39.76%$60.1K-1.86%Stalk
Mar 3, 2025SellTRDANatarajan SethuramanPresident, Research & Develop.6,138$11.68$267.5M-58.12%+39.76%$71.7K-2.07%Stalk
Mar 3, 2025SellTRDADipal DoshiCEO17,566$11.68$267.5M-58.12%+39.76%$205.1K-2.85%Stalk
Nov 29, 2024SellTRDAKory James WentworthChief Financial Officer12,000$11.05$267.5M-58.12%+39.76%$132.5K+0.00%10b5-1Stalk
Nov 29, 2024SellTRDANatarajan SethuramanPresident, Research & Develop.15,891$20.18$267.5M-58.12%+39.76%$320.6K-3.32%10b5-1Stalk
Nov 11, 2024SellTRDANatarajan SethuramanPresident, Research & Develop.4,109$20.03$267.5M-58.12%+39.76%$82.3K-1.25%10b5-1Stalk
Nov 11, 2024SellTRDAKory James WentworthChief Financial Officer14,637$12.65$267.5M-58.12%+39.76%$185.2K-1.34%10b5-1Stalk
Nov 4, 2024SellTRDANatarajan SethuramanPresident, Research & Develop.18,219$18.62$267.5M-58.12%+39.76%$339.3K-2.56%10b5-1Stalk
Oct 16, 2024SellTRDANatarajan SethuramanPresident, Research & Develop.600$18.00$267.5M-58.12%+39.76%$10.8K-0.33%10b5-1Stalk
Sep 26, 2024SellTRDANathan J DowdenPresident & COO847$16.00$267.5M-58.12%+39.76%$13.6K-0.67%10b5-1Stalk
Sep 9, 2024SellTRDAKory James WentworthChief Financial Officer3,195$14.97$267.5M-58.12%+39.76%$47.8K-4.01%10b5-1Stalk
Sep 6, 2024SellTRDANathan J DowdenPresident & COO2,303$15.09$267.5M-58.12%+39.76%$34.8K-0.90%10b5-1Stalk
Sep 6, 2024SellTRDANatarajan SethuramanChief Scientific Officer3,242$15.12$267.5M-58.12%+39.76%$49.0K-0.87%10b5-1Stalk
Sep 3, 2024SellTRDAKory James WentworthChief Financial Officer1,731$15.63$267.5M-58.12%+39.76%$27.1K-0.43%Stalk
Sep 3, 2024SellTRDANatarajan SethuramanChief Scientific Officer1,756$15.63$267.5M-58.12%+39.76%$27.5K-0.19%Stalk
Sep 3, 2024SellTRDANathan J DowdenPresident & COO1,808$15.63$267.5M-58.12%+39.76%$28.3K-0.28%Stalk
Sep 3, 2024SellTRDADipal DoshiCEO8,722$15.63$267.5M-58.12%+39.76%$136.4K-0.53%Stalk
Aug 16, 2024SellTRDANathan J DowdenPresident & COO47,097$10.10$267.5M-58.12%+39.76%$475.6K-1.45%10b5-1Stalk
Jul 12, 2024SellTRDANatarajan SethuramanChief Scientific Officer1,238$18.00$267.5M-58.12%+39.76%$22.3K-0.33%10b5-1Stalk
Jul 12, 2024SellTRDADipal DoshiCEO1,900$17.84$267.5M-58.12%+39.76%$33.9K-0.28%10b5-1Stalk
Jul 8, 2024SellTRDAKory James WentworthChief Financial Officer1,758$14.95$267.5M-58.12%+39.76%$26.3K-2.11%10b5-1Stalk
Jun 13, 2024SellTRDADipal DoshiCEO1,000$16.17$267.5M-58.12%+39.76%$16.2K-0.30%10b5-1Stalk
May 16, 2024SellTRDADipal DoshiCEO3,000$15.04$267.5M-58.12%+39.76%$45.1K-0.44%10b5-1Stalk
May 16, 2024SellTRDANatarajan SethuramanChief Scientific Officer18,980$15.16$267.5M-58.12%+39.76%$287.7K-3.08%10b5-1Stalk
Mar 15, 2024BuyTRDAKory James WentworthChief Financial Officer9,000$2.10$267.5M-58.12%+39.76%$18.9K+7.67%Stalk
Mar 6, 2024SellTRDANathan J DowdenPresident & COO1,826$12.32$267.5M-58.12%+39.76%$22.5K-1.31%10b5-1Stalk
Mar 6, 2024SellTRDAKory James WentworthChief Financial Officer4,086$12.31$267.5M-58.12%+39.76%$50.3K-5.22%10b5-1Stalk
Mar 4, 2024SellTRDAKory James WentworthChief Financial Officer2,215$12.50$267.5M-58.12%+39.76%$27.7K-0.77%Stalk
Mar 4, 2024SellTRDANathan J DowdenPresident & COO2,238$12.50$267.5M-58.12%+39.76%$28.0K-0.47%Stalk
Mar 4, 2024SellTRDANatarajan SethuramanChief Scientific Officer2,266$12.50$267.5M-58.12%+39.76%$28.3K-0.32%Stalk
Mar 4, 2024SellTRDADipal DoshiCEO7,604$12.50$267.5M-58.12%+39.76%$95.0K-0.63%Stalk
Feb 15, 2024SellTRDADipal DoshiCEO1,000$15.00$267.5M-58.12%+39.76%$15.0K-0.41%10b5-1Stalk
Jan 16, 2024SellTRDADipal DoshiCEO1,000$15.99$267.5M-58.12%+39.76%$16.0K-0.41%10b5-1Stalk
Dec 21, 2023SellTRDAKory James WentworthChief Financial Officer25,000$8.84$267.5M-58.12%+39.76%$221.1K+0.00%10b5-1Stalk
Dec 20, 2023SellTRDADipal DoshiPresident and CEO1,000$15.00$267.5M-58.12%+39.76%$15.0K-0.41%10b5-1Stalk
Nov 13, 2023SellTRDADipal DoshiPresident and CEO1,000$16.23$267.5M-58.12%+39.76%$16.2K-0.40%10b5-1Stalk
Oct 17, 2023SellTRDADipal DoshiPresident and CEO1,000$15.00$267.5M-58.12%+39.76%$15.0K-0.40%10b5-1Stalk
Sep 13, 2023SellTRDADipal DoshiPresident and CEO1,000$15.00$267.5M-58.12%+39.76%$15.0K-0.40%10b5-1Stalk
Sep 5, 2023SellTRDANatarajan SethuramanChief Scientific Officer449$14.46$267.5M-58.12%+39.76%$6.5K-0.24%Stalk
Sep 5, 2023SellTRDANerissa KreherChief Medical Officer1,293$13.78$267.5M-58.12%+39.76%$17.8K-0.90%10b5-1Stalk
Sep 5, 2023SellTRDAKory James WentworthChief Financial Officer1,376$13.78$267.5M-58.12%+39.76%$19.0K-0.80%10b5-1Stalk
Sep 5, 2023SellTRDANathan J DowdenChief Operating Officer1,408$13.77$267.5M-58.12%+39.76%$19.4K-0.84%10b5-1Stalk
Sep 5, 2023SellTRDADipal DoshiPresident and CEO1,440$14.46$267.5M-58.12%+39.76%$20.8K-0.44%Stalk
Aug 14, 2023SellTRDADipal DoshiPresident and CEO1,000$15.67$267.5M-58.12%+39.76%$15.7K-0.49%10b5-1Stalk